Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

Background Inhaled corticosteroid (ICS) use could decrease local immunity of the lung. Concerns have been raised regarding the risk of tuberculosis (TB) development among ICS users. The aim of this ...

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the ...

The Drug That Could Revolutionize the Fight Against H.I.V. World leaders are dismantling global health programs and cutting back foreign aid.

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

New strategies for managing TB-DRESS emphasize personalized care, topical therapies, and selective reintroduction protocols, offering hope for better outcomes in HIV co-infected tuberculosis patients.

In a major breakthrough for communities in crisis in the Democratic Republic of Congo (DRC), the United Nations Development Programme (UNDP) and the The Global Fund to Fight AIDS, Tuberculosis and ...